04:32:22 EDT Fri 04 Jul 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Hydreight Technologies Inc
Symbol NURS
Shares Issued 44,857,983
Close 2025-05-27 C$ 1.96
Market Cap C$ 87,921,647
Recent Sedar Documents

Hydreight Technologies releases genetic testing tool

2025-05-27 17:46 ET - News Release

Also News Release (C-VST) Victory Square Technologies Inc

Mr. Shane Madden of Hydreight reports

HYDREIGHT LAUNCHES PERSONALIZED GENETIC TESTING AND WELLNESS SOLUTION ON VSDHONE PLATFORM

Hydreight Technologies Inc. has launched a new direct-to-consumer genetic testing and personalized wellness solution via its VSDHOne platform.

The new offering enables patients to easily access at-home DNA testing kits and receive personalized health plans based on their unique genetic profile. These plans include insights on nutrition, fitness, supplementation and medication compatibility -- creating a highly individualized approach to health optimization. Once their results are available, patients can seamlessly continue their care journey on Hydreight's VSDHOne platform, where licensed providers can deliver tailored treatments, prescribe wellness protocols and support patients through telehealth and in-person services.

Key features include:

  • At-home DNA swab kit;

  • Lab-based genetic sequencing and analysis;

  • Personalized health and wellness recommendations;

  • Consultation with genetic expert licensed prescriber review;

  • Supplement and medication guidance tailored to genetic markers;

  • Nationwide fulfilment and home delivery.

This launch positions Hydreight's 3,000-plus nurses, 200-plus physicians, 400-plus D2C brands and multiple white-label wellness partners to immediately offer this service to clients, increasing revenue and patient retention through proactive, personalized care.

Expanding access to preventive health care

With 70-per-cent of chronic diseases driven by lifestyle and environmental factors (CDC), tailoring wellness support to an individual's genetics enables a more pro-active, preventive approach to care. Hydreight's new offering puts these personalized insights directly into consumers' hands, bypassing traditional barriers and empowering earlier intervention for better outcomes.

According to industry reports, the global consumer genomics market is expected to surpass $50-billion by 2030 (Global Market Insights), with strong tailwinds from increased demand for longevity solutions, personalized medicine and pro-active health strategies. The at-home testing market alone is projected to exceed $15-billion by 2028.

This launch gives Hydreight's nationwide network of 3,000-plus nurses, 200-plus physicians, 400-plus D2C brands and multiple white-label franchise partners the ability to offer genetic testing and personalized regimens directly to their patients -- without the overhead of brick-and-mortar lab infrastructure.

"We're turning insights into action," said Shane Madden, chief executive officer of Hydreight Technologies. "With this launch, Hydreight is moving upstream in the care journey -- helping consumers understand their health at the genetic level and take meaningful, personalized steps to optimize their wellness. It's a win for patients, providers and partners across our ecosystem. We also believe this will be a key driver of VSDHOne order volume in the second half of 2025, as our partners tap into new demand and deliver more value through personalized, data-driven care."

A scalable, recurring revenue model

The offering is structured around a subscription-based model, with upfront revenue from testing and recurring monthly revenue from tailored health regimens and supplement delivery. The integration into VSDHOne allows D2C brands and medical professionals to embed genetic testing into their offerings instantly, driving higher customer retention and lifetime value (LTV).

Hydreight's genetic testing initiative supports its 2025 priorities, including:

  • Expanding high-margin white-label services;

  • Scaling onboarding of licensed D2C brands;

  • Growing pharmacy margins and patient lifetime value;

  • Launching new wellness categories like TRT, peptides, NAD+ and longevity protocols.

Hydreight's proprietary platform is already compliant in all 50 states, delivering end-to-end infrastructure -- from prescription generation and telehealth to pharmacy fulfilment and payments -- for thousands of health care providers and consumer health brands.

Now, with the addition of genetic testing and personalized wellness solutions, Hydreight is positioning itself as the "Stripe meets Shopify for health care": a plug-and-play engine powering the future of personalized, mobile-first and direct-to-consumer care delivery.

About Hydreight Technologies Inc.

Hydreight is building one of the largest mobile clinic networks in the United States. Its proprietary, fully integrated platform hosts a network of over 2,500 nurses, over 100 doctors and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking and managing patient data, which enable licensed health care professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians and other licensed health care professionals. The Hydreight platform allows health care professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states, and is closely affiliated with a U.S. certified e-script and telemedicine provider network.

About VSDHOne

VSDHOne is a direct-to-consumer platform developed in partnership with Victory Square Technologies. VSDHOne simplifies the entry challenges for companies and medi-spa businesses to enter the on-line health care space compliantly. This platform will help all businesses to launch a direct-to-consumer health care brand in a matter of days in all 50 states.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.